SYNLAB AG’s acquisition of the remaining 49% of SYNLAB Nigeria Limited’s operations in Nigeria for €8.6 million

Lead party: SYNLAB AG (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: SYNLAB Nigeria Limited (private company) · Sector: Healthcare, Specialty Healthcare Providers · Countries of operation: Nigeria Transaction type: Merger/Acquisition(M&A) · Asset class: Corporate Transactions · Strategy: Buyout · Instrument: Equity · Deal amount: US$10.1m · Equity stake: 0.49% ·…


Lead party: SYNLAB AG (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: SYNLAB Nigeria Limited (private company) · Sector: Healthcare, Specialty Healthcare Providers · Countries of operation: Nigeria

Transaction type: Merger/Acquisition(M&A) · Asset class: Corporate Transactions · Strategy: Buyout · Instrument: Equity · Deal amount: US$10.1m · Equity stake: 0.49% · Implied EV: US$20.6m

Lead investor/buyer: SYNLAB AG · Investors/buyers: SYNLAB AG

Legal advisers: not identified in the source record.

Source: announced 8 August 2021. Original announcement: synlab.ag.